Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Vycor Medical (VYCO) Other Non Operating Income (2017 - 2025)

Vycor Medical has reported Other Non Operating Income over the past 12 years, most recently at $130.0 for Q4 2025.

  • Quarterly Other Non Operating Income rose 490.91% to $130.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$508.0 through Dec 2025, down 120.87% year-over-year, with the annual reading at -$508.0 for FY2025, 120.87% down from the prior year.
  • Other Non Operating Income was $130.0 for Q4 2025 at Vycor Medical, up from -$640.0 in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $130.0 in Q4 2025 and troughed at -$672.0 in Q1 2022.
  • The 5-year median for Other Non Operating Income is -$65.5 (2023), against an average of -$144.06.
  • Year-over-year, Other Non Operating Income plummeted 675.0% in 2023 and then skyrocketed 633.33% in 2024.
  • A 5-year view of Other Non Operating Income shows it stood at -$313.0 in 2021, then surged by 132.27% to $101.0 in 2022, then tumbled by 97.03% to $3.0 in 2023, then skyrocketed by 633.33% to $22.0 in 2024, then soared by 490.91% to $130.0 in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Other Non Operating Income are $130.0 (Q4 2025), -$640.0 (Q3 2025), and $1.0 (Q2 2025).